PharmaShots | Incisive News in 3 Shots

Subscribe Now

Xbran

Xbrane Resubmit the BLA for Ranibizumab Biosimilar to Treat Serious Eye Disease

Xbrane Resubmit the BLA for Ranibizumab Biosimilar to Treat Serious Eye Disease

July 4, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us